Blend Labs (NYSE:BLND - Get Free Report) is projected to post its Q1 2026 results after the market closes on Thursday, May 7th. Analysts expect Blend Labs to post earnings of $0.02 per share and revenue of $30.0330 million for the quarter. Individuals can check the company's upcoming Q1 2026 earning summary page for the latest details on the call scheduled for Thursday, May 7, 2026 at 4:30 PM ET.
Blend Labs Stock Down 0.3%
Blend Labs stock opened at $1.43 on Thursday. Blend Labs has a 12-month low of $1.33 and a 12-month high of $4.49. The firm's fifty day moving average is $1.64 and its 200 day moving average is $2.48. The company has a market capitalization of $366.39 million, a PE ratio of -14.25 and a beta of 1.22.
Institutional Inflows and Outflows
Institutional investors have recently bought and sold shares of the business. Revolve Wealth Partners LLC acquired a new position in Blend Labs during the fourth quarter worth $132,000. Tower Research Capital LLC TRC raised its holdings in Blend Labs by 571.1% during the second quarter. Tower Research Capital LLC TRC now owns 31,953 shares of the company's stock worth $105,000 after buying an additional 27,192 shares during the last quarter. State of Wyoming raised its holdings in Blend Labs by 61.0% during the second quarter. State of Wyoming now owns 31,962 shares of the company's stock worth $105,000 after buying an additional 12,115 shares during the last quarter. Cerity Partners LLC grew its stake in shares of Blend Labs by 58.8% in the 2nd quarter. Cerity Partners LLC now owns 29,345 shares of the company's stock worth $97,000 after acquiring an additional 10,862 shares in the last quarter. Finally, CIBC Bancorp USA Inc. bought a new stake in shares of Blend Labs in the 3rd quarter worth $82,000. Institutional investors and hedge funds own 52.56% of the company's stock.
Analysts Set New Price Targets
A number of research analysts recently issued reports on the stock. UBS Group dropped their target price on shares of Blend Labs from $3.00 to $2.00 and set a "neutral" rating on the stock in a research report on Wednesday, March 11th. Wells Fargo & Company dropped their target price on shares of Blend Labs from $5.00 to $4.00 and set an "overweight" rating on the stock in a research report on Wednesday, March 11th. Citizens Jmp dropped their target price on shares of Blend Labs from $7.00 to $5.00 and set a "market outperform" rating on the stock in a research report on Wednesday, March 11th. Finally, Weiss Ratings reiterated a "sell (d-)" rating on shares of Blend Labs in a research report on Monday, April 20th. Four investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average target price of $4.13.
Get Our Latest Stock Report on Blend Labs
About Blend Labs
(
Get Free Report)
Blend Labs, Inc operates as a financial technology company that offers a digital consumer banking platform designed to simplify and automate the lending and account opening processes for banks and credit unions. Its cloud-native software enables financial institutions to deliver a more seamless customer experience by consolidating multiple steps—such as application intake, identity verification, document collection and underwriting—into a unified digital workflow. Blend's platform is built to integrate with existing core banking systems and third-party data providers, allowing clients to accelerate loan origination and deposit account opening while maintaining compliance and security standards.
The company's product suite includes solutions for mortgage origination, home equity lending, consumer personal lending and deposit account opening.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Blend Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Blend Labs wasn't on the list.
While Blend Labs currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Spring 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.